Chicago Partners Investment Group LLC bought a new stake in MetLife, Inc. (NYSE:MET – Free Report) during the third quarter, HoldingsChannel reports. The firm bought 2,774 shares of the financial services provider’s stock, valued at approximately $233,000.
Several other large investors have also modified their holdings of the stock. Wolff Wiese Magana LLC raised its stake in MetLife by 374.3% during the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after buying an additional 277 shares in the last quarter. Fortitude Family Office LLC lifted its stake in MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 266 shares during the last quarter. Bank & Trust Co acquired a new position in MetLife in the second quarter worth $39,000. Crewe Advisors LLC increased its stake in MetLife by 602.5% during the second quarter. Crewe Advisors LLC now owns 562 shares of the financial services provider’s stock valued at $39,000 after purchasing an additional 482 shares during the last quarter. Finally, Larson Financial Group LLC raised its holdings in shares of MetLife by 72.6% during the second quarter. Larson Financial Group LLC now owns 568 shares of the financial services provider’s stock worth $40,000 after purchasing an additional 239 shares during the period. Institutional investors own 89.81% of the company’s stock.
MetLife Stock Performance
Shares of MET opened at $78.15 on Wednesday. The firm has a market capitalization of $54.73 billion, a PE ratio of 15.76, a P/E/G ratio of 0.71 and a beta of 1.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.49. The firm has a 50-day moving average price of $80.73 and a 200 day moving average price of $75.03. MetLife, Inc. has a 52-week low of $58.89 and a 52-week high of $86.94.
MetLife Dividend Announcement
Analyst Upgrades and Downgrades
Several research analysts have recently commented on the stock. Citigroup lifted their price target on shares of MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Morgan Stanley decreased their target price on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Monday, August 19th. StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research report on Friday, October 4th. Piper Sandler boosted their price objective on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Finally, Bank of America dropped their target price on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research report on Thursday, August 1st. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $88.46.
Check Out Our Latest Report on MetLife
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Stock Average Calculator
- Palantir Cracks $50, Is There Still Time to Get on Board?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Insider Buying Signals Upside for These 3 Stocks
- Stock Splits, Do They Really Impact Investors?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.